Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
genetic toxicity in vivo, other
Remarks:
in vivo micronucleus QSAR
Type of information:
(Q)SAR
Adequacy of study:
key study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
results derived from a valid (Q)SAR model and falling into its applicability domain, with adequate and reliable documentation / justification

Data source

Reference
Reference Type:
other company data
Title:
Unnamed
Year:
2016
Report date:
2016

Materials and methods

Test guideline
Qualifier:
no guideline available
Principles of method if other than guideline:
Times v.2.27.19.13 in QSAR Toolbox
Toolbox prediction report is attached in IUCLID
GLP compliance:
no

Test material

Constituent 1
Chemical structure
Reference substance name:
Myo-inositol
EC Number:
201-781-2
EC Name:
Myo-inositol
Cas Number:
87-89-8
Molecular formula:
C6H12O6
IUPAC Name:
cyclohexane-1,2,3,4,5,6-hexol
Details on test material:
- Purity: Not applicable
- Smiles: OC1C{P-}(O)C{P-}(O)C{P-}(O)C{P+}(O)C{P-}1O
Specific details on test material used for the study:
SMILES: OC1C{P-}(O)C{P-}(O)C{P-}(O)C{P+}(O)C{P-}1O

Results and discussion

Test results
Key result
Genotoxicity:
negative
Remarks:
Mammalian erythrocytes and/or peripheral blood
Remarks on result:
other: no mutagenic potential (based on QSAR/QSPR prediction)

Applicant's summary and conclusion

Conclusions:
Negative
Executive summary:

The Times model for in vivo micronucleus assay was used within the QSAR Toolbox. The prediction was negative. Additional supporting documentation is provided in the prediction report attached in IUCLID.